+410 533 4567
Anadrol by LA Pharma S.R.L. is an ultra-potent, pharmaceutical-grade oral anabolic steroid featuring pure Oxymetholone at a concentration of 50mg per tablet in a container of 100 tablets (5,000mg total active compound). Widely regarded as the single most powerful oral anabolic compound in sports science and competitive bodybuilding, Anadrol is manufactured under strict quality controls to deliver extreme muscle mass gains, dramatic power output, and exceptional cellular fullness.
Derived from Dihydrotestosterone (DHT) and modified with a $17\alpha$-alkyl group and a 2-hydroxymethylene alteration, Oxymetholone exhibits an extraordinary 450:45 anabolic-to-androgenic ratio. Anadrol is specifically engineered for heavy bulking protocols and rapid strength development. Beyond its direct anabolic activity, Oxymetholone heavily stimulates red blood cell production (erythropoiesis), producing extreme intramuscular blood flow, full muscle bellies, and intense pump effects during resistance training.
Key Benefits & Applications
-
Unrivaled Rapid Mass & Weight Accretion: Triggers rapid body weight and sheer muscle volume gains within the first 1 to 2 weeks, serving as the ultimate heavy kick-start agent for bulking cycles.
-
Massive Muscle Pumps & Erythropoiesis: Heavily stimulates endogenous erythropoietin (EPO) release, increasing red blood cell count and intravascular oxygen transport for extreme training endurance and massive muscle pumps.
-
Explosive Raw Power & Joint Cushioning: Drives immediate increases in maximal lifting capacity while promoting fluid retention around joints and connective tissues, facilitating heavy compound pressing and squatting.
-
Strong Protein Synthesis & Cellular Hydration: Dramatically accelerates cellular nitrogen retention and protein translation, creating an intense hyper-anabolic growth state.
-
High-Capacity Supply: The 100-tablet presentation of 50mg tablets provides complete protocol flexibility and long-term supply for structured bulking cycles.
Reviews
There are no reviews yet.